/ about
The 2022 Updates in GI Educational Conference will deliver focused, educational updates highlighting clinically relevant advances in the management of patients with gastrointestinal (GI) disorders and chronic liver disease (CLD). It will feature an interactive format to enhance the educational impact.
Internationally renowned gastroenterologists and hepatologists will lead the development of educational content and will serve as program faculty. The faculty will review state-of-the-art developments in gastrointestinal (GI) disorders and chronic liver disease (CLD), including, but not limited to:
-
Endoscopic Obesity
-
Inflammatory Bowel Disease (IBD)
-
Irritable Bowel Syndrome (IBS)
-
Alternative Medicine & Diet in GI
-
Clostridioides difficile (C. diff)
-
Hepatic Encephalopathy (HE)
-
Hepatorenal Syndrome (HRS)
-
Acute Pancreatitis
-
IBS with Alternating Constipation and Diarrhea
(IBS C and D)
/ CME AGENDA TOPICS
THURSDAY, OCTOBER 20, 2022
6:30 – 7:30 PM
Exhibits and Welcome Reception - Charlotte Ballroom ABC
7:30 – 8:30 PM
CME Dinner Symposium - Charlotte Ballroom DE
Improving Health Outcomes in the Cirrhotic Patient
David Eric Bersntein, MD, PC
New York, NY
8:30 – 10:00 PM
Exhibits - Reception - Charlotte Ballroom ABC
FRIDAY, OCTOBER 21, 2022
Session I: CME (All Providers)
Charlotte Ballroom DE
7:00 AM – 12:15 PM
7:00 – 8:00 AM
Breakfast / Exhibits
8:00 – 8:45 AM
Breakfast/Sponsor Product Theater: Ardelyx
An Innovative Approach for the Treatment
of Adults With Irritable Bowel Syndrome
With Constipation (IBS-C)
Darren M. Brenner, MD, FACG, AGAF, RFF
Professor of Medicine and Surgery
IDP Foundation Research Scholar
Director, Northwestern Neurogastromotility and
Interdisciplinary Bowel Dysfunction
Programs Director, Motts Tonelli GI Physiology Laboratory
Northwestern University Feinberg School of Medicine
Chicago, IL
9:15 – 9:20 AM
Welcome
Eugenio J. Hernandez, MD
Gastroenterologist and Senior Vice President of Clinical Affairs
Gastro Health Florida
Miami, FL
9:20 – 9:45 AM
Endoscopic Obesity Management
Jeremias C. Tan, MD
Co-Director of Health & Wellness, Mid-Atlantic Region
Endobariatric Weight loss Specialist Gastro Health
Fairfax, VA
9:45 – 10:10 AM
IBD Update
Stephen Hanauer, MD
Professor of Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL
10:10 – 10:35 AM
The Psycho-Social Component of
Health in IBS and IBD
Marla C. Dubinsky, MD
Professor of Pediatrics and Medicine
Chief, Division of Pediatric Gastroenterology and Nutrition
Co-Director, Susan and Leonard Feinstein IBD Center
Director, Marie and Barry Lipman IBD Preconception and Planning Clinic
Mount Sinai Kravis Children’s Hospital
Icahn School of Medicine Mount Sinai New York
New York, New York
10:35 – 11:00 AM
Diet and Alternative Medicine for IBS
Kate Scarlata, MPH, RDN
For a Digestive Peace of Mind, LLC
Medway, MA
11:00 – 11:10 AM
Break
11:10 – 11:30 AM
Radiology in GI Practice
Sandeep Bagla, MD
Prostate Centers USA, LLC
Hemorrhoid Centers USA, LLC
Vascular Interventional Partners NOVA
Falls Church, VA
11:30 – 11:50 AM
Hemorrhoids: Treatment Approaches for
the Gastroenterologist
George Dickstein, MD, FASGE, AGAF
Academic Dean and Associate Clinical Professor of Medicine,
Tufts University School of Medicine
Vice President of Clinical Affairs, Gastro Health
Framingham, MA
11:50 AM – 12:15 PM
Management of IBS C and D
Anthony Lembo, MD
Director of the GI Motility and Functional Bowel
Disorders Program at Beth Israel Deaconess Medical Cente
Professor of Medicine
Harvard Medical School
Boston, MA
12:15 – 12:45 PM
Break
12:45 – 1:30 PM
Lunch/Sponsor Product Theater Janssen Biotech
STELARA® (ustekinumab): A FIRST-LINE BIOLOGIC OPTION WITH REAL-WORLD EVIDENCE
Bruce Salzberg, MD FACG
Gastroenterologist
Atlanta Gastroenterology Specialists
Atlanta, GA
Session II: CME (APPs)
Charlotte Ballroom FGH
1:00 – 2:50 PM
1:00 – 1:25 PM
Management of Acute Pancreatitis / Complications
Andres Gelrud, MD, MMSc
Gastroenterologist
Gastro Health
Miami, FL
1:25 – 1:50 PM
Breaking News in the Management of HRS-AKI
Patrick M. Horne, MSN, APRN, FNP-BC, AF-AASLD
Assistant Director of Clinical Hepatology Research/
Clinical Programs Coordinator
University of Florida
Department of Medicine
Division of Gastroenterology, Hepatology, and Nutrition
Gainesville, FL
1:50 – 2:00 PM
Break
2:00 – 2:25 PM
HE Transition of Care
Elizabeth K. Goacher, PA-C, MHS
Advanced Practice Provider
Team Lead, Division of Gastroenterology
Lead, Department of Medicine Advanced Practice Providers
Duke University Hospital
Durham, NC
2:25 – 2:50 PM
C. difficile Management Updates
Carol M. Antequera, DMSc, PA-C
Physician Associate
Division of Gastroenterology, Department of Medicine
University of Miami Miller School of Medicine
Miami, FL
2:50 PM
Adjourn
6:00 – 8:00 PM
Reception†
*This agenda is subject to change.
† Exclusive sponsorship.
/ COURSE DIRECTORS
Raj Devarajan, MD
Gastroenterologist with
Gastro Health Massachusetts
Acton, Massachusetts
George Dickstein, MD, FASGE, AGAF
Gastroenterologist and Vice President of Clinical Affairs,
Gastro Health Massachusetts
Framingham, Massachusetts
Eugenio J. Hernandez, MD
Gastroenterologist and Senior Vice President of Clinical Affairs
Gastro Health Florida
Miami, Florida
/ OBJECTIVES
Learning Objectives
Upon completion of this educational activity, participants should be able to:
-
Describe current screening, diagnosis, and management options for patients with
gastrointestinal (GI) disorders and chronic liver disease (CLD) -
Apply optimal treatment strategies for patients with GI disorders and CLD
-
Compare and contrast currently available treatment modalities for GI disorders and CLD
/ CME accreditation
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Focus Medical Communications. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
All additional planning committee members, the University of Cincinnati staff and Focus Medical Communications staff have no relationships to disclose.
Learner Assurance Statement
The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Disclaimer Statement
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.
Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
Americans With Disabilities Act
The event staff will be glad to assist you with any special needs (ie, physical, dietary). Please contact us prior to the event at 1-877-782-4532.